Abstract Purpose To investigate the feasibility of shear wave sonoelastography (SWS) for endoleak detection and thrombus characterization of abdominal aortic aneurysm (AAA) after endovascular repair (EVAR). Materials and methods Participants who underwent EVAR were prospectively recruited between November 2014 and March 2016 and followed until March...
02:00
Condition: Breast Neoplasm Malignant Female Interventions: Drug: Letrozole; Other: standard-stimulated cohort Sponsors: Erasme University Hospital; University Hospital, Lille Recruiting (Source: ClinicalTrials.gov)MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.
Mon Mar 02, 2020 18:00
Conditions: Female Breast Carcinoma; Healthy Subject Interventions: Other: Questionnaire Administration; Behavioral: Telephone-Based Intervention Sponsors: Fox Chase Cancer Center; National Cancer Institute (NCI) Completed (Source: ClinicalTrials.gov)
Mon Mar 02, 2020 18:00
Condition: Breast Cancer Intervention: Procedure: Vacuum assisted biopsy (VAB) Sponsor: Swiss Group for Clinical Cancer Research Not yet recruiting (Source: ClinicalTrials.gov)
Mon Mar 02, 2020 18:00
Condition: Lymphoma and Acute Lymphoblastic Leukemia Intervention: Other: additional biological samples during CAR-T CELL treatment Sponsor: University Hospital, Montpellier Not yet recruiting (Source: ClinicalTrials.gov)
Mon Mar 02, 2020 18:00
Condition: Prostate Adenocarcinoma Intervention: Drug: Niraparib Pill Sponsor: Abramson Cancer Center of the University of Pennsylvania Not yet recruiting (Source: ClinicalTrials.gov)
Mon Mar 02, 2020 18:00
Condition: Pancreatic Cancer Intervention: Other: Palliative care Sponsor: Inge Høgh Dufva Recruiting (Source: ClinicalTrials.gov)
Mon Mar 02, 2020 18:00
Conditions: Prostate Cancer Detection; Fusion Prostate Biopsy Intervention: Diagnostic Test: cognitive vs software Sponsor: Hospital Universitari Vall d'Hebron Research Institute Recruiting (Source: ClinicalTrials.gov)MedWorm Message: If you are looking to buy something in the January Sales please visit TheJanuarySales.com for a directory of all the best sales in the UK. Any income gained via affiliate links keeps MedWorm running.
Mon Mar 02, 2020 18:00
Conditions: NSCLC Stage IV; Brain Metastases; Immunotherapy Interventions: Drug: Immunotherapy; Radiation: WBRT Sponsor: Zhejiang Cancer Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Mon Mar 02, 2020 18:00
Condition: HER2-positive Breast Cancer Intervention: Other: Acquisition of blood samples and tumour tissue samples (biopsies) Sponsors: King's College London; Guy's and St Thomas' NHS Foundation Trust; Brighton and Sussex University Hospitals NHS Trust Recruiting (Source: ClinicalTrials.gov)
Mon Mar 02, 2020 18:00
Conditions: Colorectal Cancer; Oncologic Complications and Emergencies Intervention: Procedure: Curative resection of colorectal cancer Sponsor: University of Alexandria Completed (Source: ClinicalTrials.gov)
Mon Mar 02, 2020 18:00
Conditions: Stage I Prostate Cancer AJCC v8; Stage II Prostate Cancer AJCC v8; Stage IIA Prostate Cancer AJCC v8; Stage IIB Prostate Cancer AJCC v8; Stage IIC Prostate Cancer AJCC v8; Stage III Prostate Cancer AJCC v8; Stage IIIA Prostate Cancer AJCC v8; Stage IIIB Prostate Cancer AJCC v8; Stage IIIC Prostate Cancer AJCC v8 Interventions: Other: Food Diary; Other: Preventative Dietary Intervention; Other: Questionnaire Administration Sponsors: Mayo Clinic; National Cancer Institute (NCI)...
Mon Mar 02, 2020 18:00
Conditions: Liver Cancer; Liver Cirrhoses; Liver Carcinoma Intervention: Drug: Gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid Sponsors: University of California, San Diego; Bayer Healthcare Pharmaceuticals, Inc./Bayer Schering Pharma; Icahn School of Medicine at Mount Sinai Recruiting (Source: ClinicalTrials.gov)
Mon Mar 02, 2020 18:00
Condition: Triple Negative Breast Cancer Intervention: Procedure: Needle core biopsy Sponsor: University of Arizona Not yet recruiting (Source: ClinicalTrials.gov)
Mon Mar 02, 2020 18:00
Condition: Gastric Cancer Intervention: Procedure: No drain placement Sponsor: THEODOROU DIMITRIOS Not yet recruiting (Source: ClinicalTrials.gov)
Mon Mar 02, 2020 18:00
Conditions: Merkel Cell Carcinoma; Merkel Cell Carcinoma, Stage I; Merkel Cell Carcinoma, Stage II; Merkel Cell Carcinoma, Stage III; Neuroendocrine Tumors; Carcinoma Neuroendocrine Skin Interventions: Drug: Avelumab; Drug: Placebo Sponsor: Melanoma and Skin Cancer Trials Limited Not yet recruiting (Source: ClinicalTrials.gov)
Mon Mar 02, 2020 18:00
Condition: Rectal Cancer Recurrent Interventions: Drug: Chemotherapy; Radiation: Preoperative radiotherapy; Other: Procedure Sponsors: National Cancer Center Hospital East; Japan Clinical Oncology Group; Japan Agency for Medical Research and Development Recruiting (Source: ClinicalTrials.gov)
Mon Mar 02, 2020 18:00
Conditions: Prostate Cancer; Metabolic Syndrome; Intermittent Fasting Intervention: Other: Fasting mimicking diet Sponsor: Galway Clinic Active, not recruiting (Source: ClinicalTrials.gov)
Mon Mar 02, 2020 18:00
Conditions: Glioblastoma; High Grade Glioma; Recurrent Glioblastoma; Melanoma; Advanced Cancer Intervention: Drug: GX-I7 Sponsor: Genexine, Inc. Available (Source: ClinicalTrials.gov)MedWorm Message: If you are looking to buy something in the January Sales please visit TheJanuarySales.com for a directory of all the best sales in the UK. Any income gained via affiliate links keeps MedWorm running.
Mon Mar 02, 2020 18:00
Condition: Advanced Malignant Mesothelioma Intervention: Drug: HMPL-453 Sponsor: Hutchison Medipharma Limited Not yet recruiting (Source: ClinicalTrials.gov)
Mon Mar 02, 2020 18:00
Conditions: Non Small Cell Lung Cancer; Non-Small Cell Carcinoma of Lung; Non Small Cell Lung Cancer Stage III; Non-small Cell Lung Cancer Stage IV Intervention: Other: TMB assessment Sponsors: Assistance Publique - Hôpitaux de Paris; Bristol-Myers Squibb Not yet recruiting (Source: ClinicalTrials.gov)
Mon Mar 02, 2020 18:00
Conditions: Desmoid Tumor; Desmoid-type Fibromatosis Intervention: Other: Questionnaires Sponsors: Erasmus Medical Center; Radboud University; The Netherlands Cancer Institute Enrolling by invitation (Source: ClinicalTrials.gov)MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.
Mon Mar 02, 2020 18:00
First-in-human Pilot Study of an Integrin α6-targeted Radiotracer for SPECT Imaging of Breast Cancer
Condition: Breast Cancer Intervention: Drug: 99mTc-RWY Sponsor: Bing Jia Completed (Source: ClinicalTrials.gov)
Mon Mar 02, 2020 18:00
Condition: Bladder Cancer Interventions: Drug: Cabozantinib; Drug: Atezolizumab; Procedure: Cystectomy Sponsors: Deepak Kilari; Exelixis; Genentech, Inc.; Medical College of Wisconsin Not yet recruiting (Source: ClinicalTrials.gov)
Mon Mar 02, 2020 18:00
DiscussionSince low adherence rates undermine the positive impact of PSE on post-treatment swallowing function, there is need to develop an efficient PSE protocol maximizing adherence rates.Trial registrationISRCTN, ID:ISRCTN98243550. Registered retrospectively on 21 December 2018. (Source: Trials)MedWorm Message: If you are looking to buy something in the January Sales please visit TheJanuarySales.com for a directory of all the best sales in the UK. Any income gained via affiliate links keeps MedWorm...
Mon Mar 02, 2020 00:00
Authors: Magadán S Abstract The adaptive immune response in jawed vertebrates relies on the huge diversity and specificity of the B cell and T cell antigen receptors, the immunoglobulins (IG) or antibodies and the T cell receptors (TR), respectively. The high level of diversity has represented a barrier to a comprehensive analysis of the adaptive immune response before the emergence of high-throughput sequencing (HTS) technologies. The size and complexity of HTS data requires the generation...
Thu Feb 27, 2020 00:00
Authors: Mimpen M, Smolders J, Hupperts R, Damoiseaux J Abstract As the most common non-traumatic disabling disease among adolescents, multiple sclerosis (MS) is a devastating neurological inflammatory disease of the central nervous system. Research has not yet fully elucidated its pathogenesis, but it has shown MS to be a complex, multifactorial disease with many interplaying factors. One of these factors, natural killer (NK) cells, lymphocytes of the innate immune system, have recently...
Thu Feb 27, 2020 00:00
Abstract Background Valve‐in‐valve (VIV) treatment with transcatheter aortic valve replacement (TAVR) is a viable option for patients with failing aortic bioprosthetic valves. Optimal management of those with concomitant mitral regurgitation (MR) remains undetermined. Therefore, we sought to assess the implications of concomitant MR in patients undergoing VIV‐TAVR. Methods and Results The PARTNER 2 VIV registry enrolled patients with degenerated surgical aortic bioprosthesis at high...
04:36
Abstract The current gold standard diagnostic test for colorectal cancer remains histological inspections of endoluminal neoplasia in biopsy specimens. However, biopsy site selection requires visual inspection of the bowel, typically with a white‐light endoscope. Therefore, this technique is poorly suited to detect small or innocuous‐appearing lesions. We hypothesize that an alternative modality – multi‐wavelength spatial frequency domain imaging (SFDI) – would be able to differentiate various...
04:30
Abstract Having the least lenses, the significant feature of the singlet imaging system, helps the development of the portable and cost‐effective microscopes. A novel method of monochromatic/color singlet microscopy, which is combined with only one aspheric lens and deep learning computational imaging technology, is proposed in this manuscript. The designed singlet aspheric lens is an approximate linear signal system, which means modulation‐transfer‐function curves on all field‐of‐views (5mm diagonally)...
04:30
03:55
03:47
Abstract Data on antimicrobial resistance (AMR) in zoonotic and indicator bacteria from humans, animals and food are collected annually by the EU Member States (MSs), jointly analysed by EFSA and ECDC and reported in a yearly EU Summary Report. The annual monitoring of AMR in animals and food within the EU is targeted at selected animal species corresponding to the reporting year. The 2017 monitoring specifically focussed on pigs and calves under 1 year of age, as well as their derived carcases/meat,...
04:28
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου